Immunosuppressive Agents in the Treatment of Membranoproliferative Glomerulonephritis
Artículo
Acceso abierto
Artículo
DOAJ
INTRODUCTION: Treatment of membranoproliferative glomerulonephritis (MPGN) is often unrewarding with approximately 60% of patients progressing to end-stage renal failure within 10 years. In our study, we compared the eff...
LCC LCC:Internal medicine; TENDOlBlZGlhdHJpY3M~Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access